eRibo Pro Peak Differential Expression

A common end goal of an RNA-Seq experiment is to identify what genes have responded to a treatment. For example, has a newly developed drug increased the expression of a target or has a knockdown worked to decrease expression? In order to answer these questions we perform a type of analysis called differential expression (DE) analysis.

A DE analysis is a statistical procedure that identifies differentially up or downregulated genes between two or more conditions or samples. It involves comparing the expression levels of each gene in one group of samples (e.g., disease samples) to the expression levels in another (e.g., healthy samples) to identify genes that have changed across conditions. DE analysis can have a significant impact by identifying disease-associated genes (which can be used as potential drug development targets), and identify biomarkers that can be used for diagnosis, prognosis, or monitoring of disease progression.

DE analysis is typically performed using specialized software to maximize our ability to identify differences when the number of replicates by the condition is small (e.g., 2 or 3 technical repetitions) while accounting for differences in library size and false discovery rate due to multiple tests conducted all at once. At Eclipsebio, we use a powerful tool called DESeq2 to identify differentially expressed genes. One way that we use DESeq2 is with our eRibo service, where we can detect changes in  ribosome-associated and total transcriptome counts between different conditions.

DESeq2 uses information across all genes in the experiment to produce a robust estimate of the variability (dispersion) between samples for each gene in a way that considers the logarithmic nature of read count data. It then uses these dispersions to divide the log2 fold changes between conditions and calculate a statistical test called the “Wald” test. This test helps us determine whether our observed differences are likely real or just due to chance, and provides robust lists of DE genes to support answering specific scientific questions.

The same framework that is used to identify differentially expressed genes can also be applied different data modalities. For example, a similar analysis can be performed with eCLIP peaks to determine if a region has differential enrichment following a treatment. In the case of eCLIP, to account for the presence of an input we compare the ratio of fold changes rather than the observed counts in the immunoprecipitated libraries alone.

Creating the right framework for an accurate differential analysis can take a lot of effort. At Eclipsebio we have experts with extensive experience in statistical methods to take out the guesswork of identifying differential genes or peaks. Contact us today to see how we can help you examine differentials in your experiment.

Related articles

eBlogs

06
14
24

Characterization is key: how to evaluate mRNA therapeutic safety and efficacy

Before release into the clinic mRNA therapeutics need comprehensive characterization. In this eBlog we review several key aspects to profile before release...[READ MORE]

read more

eBlogs

04
30
24

RNA therapeutics: a review of the future of medicine

RNA therapeutics have revolutionized medicine. In this eBlog we discuss the different types of RNA therapeutics that have received FDA approval...[READ MORE]

read more

eBlogs

04
11
24

Discovering miRNA regulation with miR-eCLIP

miRNAs are key regulators of expression and translation, however identifying where and how they bind can be a challenge. In this eBlog we reveal how miR-eCLIP can be used to directly profile miRNA activity...[READ MORE]

read more

eBlogs

02
26
24

Successful mRNA therapeutic design: optimizing for stability and translation

mRNA therapeutics have unlocked the potential for rapid responses to infectious disease, personalized treatments for cancer, and protein replacement for different diseases. To ensure efficacy, specific features need to be included in the therapeutic to promote stability, efficient translation, and to... [READ MORE]

read more